FACTS AT A GLANCE
Edition: 15; Released: July 2021
Executive Pool: 13024
Companies: 77 – Players covered include Aegis Therapeutics LLC; AptarGroup, Inc.; AstraZeneca Plc; Becton Dickinson and Company; GlaxoSmithKline Plc; Johnson & Johnson; Marina Biotech, Inc.; MedImmune, Inc.; Merck & Co., Inc.; Nemera; Novartis AG; OptiNose US Inc.; Pfizer Inc.; Valeant Pharmaceuticals International, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Product Type (Liquid Delivery Devices, Powder Delivery Devices, Pressurized Metered Dose Inhalers, Other Product Types); Application (Respiratory Disorders, Neurological Disorders, Pain Management, Other Applications)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data…
